Sclerosing cholangitis

Jayant A. Talwalkar, Keith D. Lindor

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Primary sclerosing cholangitis in children can mimic autoimmune hepatitis in the absence of inflammatory bowel disease. Most adult patients have been identified with human leukocyte antigens that either predispose or protect against disease. Novel class I alleles and cytokine polymorphisms may also contribute to disease susceptibility. Primary α-hemolytic streptococci infection does not appear to directly cause primary sclerosing cholangitis. Promising diagnostic modalities such as single photon emission tomography require further study in comparison with cholangiographic techniques. Positron-emission tomography and DNA cytometry appear promising for confirming occult cholangiocarcinoma when present. The chemoprevention effects of ursodeoxycholic acid on colorectal dysplasia await further investigation. Initial results from high-dose ursodeoxycholic acid in halting disease progression, however, suggest a beneficial effect. In contrast, the impact of endoscopic therapy on natural history remains unresolved. Although liver transplantation continues to be effective for end-stage liver disease, disease recurrence in the allograft is a controversial topic.

Original languageEnglish (US)
Pages (from-to)372-377
Number of pages6
JournalCurrent Opinion in Gastroenterology
Volume18
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Ursodeoxycholic Acid
Sclerosing Cholangitis
Autoimmune Hepatitis
End Stage Liver Disease
Cholangiocarcinoma
Disease Susceptibility
Chemoprevention
HLA Antigens
Streptococcus
Natural History
Photons
Inflammatory Bowel Diseases
Positron-Emission Tomography
Liver Transplantation
Allografts
Disease Progression
Alleles
Tomography
Cytokines
Recurrence

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Sclerosing cholangitis. / Talwalkar, Jayant A.; Lindor, Keith D.

In: Current Opinion in Gastroenterology, Vol. 18, No. 3, 2002, p. 372-377.

Research output: Contribution to journalArticle

Talwalkar, Jayant A. ; Lindor, Keith D. / Sclerosing cholangitis. In: Current Opinion in Gastroenterology. 2002 ; Vol. 18, No. 3. pp. 372-377.
@article{ece2c6c60bab46f589e5848bf9a9c5df,
title = "Sclerosing cholangitis",
abstract = "Primary sclerosing cholangitis in children can mimic autoimmune hepatitis in the absence of inflammatory bowel disease. Most adult patients have been identified with human leukocyte antigens that either predispose or protect against disease. Novel class I alleles and cytokine polymorphisms may also contribute to disease susceptibility. Primary α-hemolytic streptococci infection does not appear to directly cause primary sclerosing cholangitis. Promising diagnostic modalities such as single photon emission tomography require further study in comparison with cholangiographic techniques. Positron-emission tomography and DNA cytometry appear promising for confirming occult cholangiocarcinoma when present. The chemoprevention effects of ursodeoxycholic acid on colorectal dysplasia await further investigation. Initial results from high-dose ursodeoxycholic acid in halting disease progression, however, suggest a beneficial effect. In contrast, the impact of endoscopic therapy on natural history remains unresolved. Although liver transplantation continues to be effective for end-stage liver disease, disease recurrence in the allograft is a controversial topic.",
author = "Talwalkar, {Jayant A.} and Lindor, {Keith D.}",
year = "2002",
doi = "10.1097/00001574-200205000-00012",
language = "English (US)",
volume = "18",
pages = "372--377",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Sclerosing cholangitis

AU - Talwalkar, Jayant A.

AU - Lindor, Keith D.

PY - 2002

Y1 - 2002

N2 - Primary sclerosing cholangitis in children can mimic autoimmune hepatitis in the absence of inflammatory bowel disease. Most adult patients have been identified with human leukocyte antigens that either predispose or protect against disease. Novel class I alleles and cytokine polymorphisms may also contribute to disease susceptibility. Primary α-hemolytic streptococci infection does not appear to directly cause primary sclerosing cholangitis. Promising diagnostic modalities such as single photon emission tomography require further study in comparison with cholangiographic techniques. Positron-emission tomography and DNA cytometry appear promising for confirming occult cholangiocarcinoma when present. The chemoprevention effects of ursodeoxycholic acid on colorectal dysplasia await further investigation. Initial results from high-dose ursodeoxycholic acid in halting disease progression, however, suggest a beneficial effect. In contrast, the impact of endoscopic therapy on natural history remains unresolved. Although liver transplantation continues to be effective for end-stage liver disease, disease recurrence in the allograft is a controversial topic.

AB - Primary sclerosing cholangitis in children can mimic autoimmune hepatitis in the absence of inflammatory bowel disease. Most adult patients have been identified with human leukocyte antigens that either predispose or protect against disease. Novel class I alleles and cytokine polymorphisms may also contribute to disease susceptibility. Primary α-hemolytic streptococci infection does not appear to directly cause primary sclerosing cholangitis. Promising diagnostic modalities such as single photon emission tomography require further study in comparison with cholangiographic techniques. Positron-emission tomography and DNA cytometry appear promising for confirming occult cholangiocarcinoma when present. The chemoprevention effects of ursodeoxycholic acid on colorectal dysplasia await further investigation. Initial results from high-dose ursodeoxycholic acid in halting disease progression, however, suggest a beneficial effect. In contrast, the impact of endoscopic therapy on natural history remains unresolved. Although liver transplantation continues to be effective for end-stage liver disease, disease recurrence in the allograft is a controversial topic.

UR - http://www.scopus.com/inward/record.url?scp=0036229854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036229854&partnerID=8YFLogxK

U2 - 10.1097/00001574-200205000-00012

DO - 10.1097/00001574-200205000-00012

M3 - Article

C2 - 17033309

AN - SCOPUS:0036229854

VL - 18

SP - 372

EP - 377

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 3

ER -